<p>Monty Pal discusses more correlates from this trial including matched baseline and progression tissue samples.</p>

Monty Pal discusses more correlates from this trial including matched baseline and progression tissue samples.

Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study

Broadcasting the latest developments in GU cancer

Hosted by Brian Rini and Tom Powles 

Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center
Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Medicine

Health & Fitness

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

Share Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study

Sign up to save your podcasts

Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study

Episode 419: ASCO 2025 - Correlate data from the IMmotion 010 RCC adjuvant study

More shows like The Uromigos

TED Radio Hour

Freakonomics Radio

Planet Money

JAMA Clinical Reviews

Behind The Knife: The Surgery Podcast

Prostate Cancer Update

ASCO Daily News

The Diary Of A CEO with Steven Bartlett

OncLive® On Air

GU Cast | Urology Podcast

Oncology Today with Dr Neil Love

People I (Mostly) Admire

ZOE Science & Nutrition

Two Onc Docs

Oncology Brothers: Practice-Changing Cancer Discussions